Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients-Reference-Cited by-同舟云学术

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

Published:2016-11-04 Issue:4 Volume:37 Page:534-541
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Eletreby Rasha¹,Elakel Wafaa¹,Said Mohamed¹,El Kassas Mohamed²,Seif Sameh³,Elbaz Tamer¹,El Raziky Maissa¹,Abdel Rehim Siham⁴,Zaky Samy⁵,Fouad Rabab¹,Gamal Eldeen Hadeel¹^ORCID,Abdo Mahmoud¹,Korany Mohamed⁶,Yosry Ayman¹,El Serafy Magdy¹,El-Sayed Manal Hamdy⁷,ElShazly Yehia⁸,Waked Imam⁹,Doss Wahid¹,Esmat Gamal¹

Affiliation:

1. Hepatology & Endemic Medicine Department; Cairo University; Cairo Egypt

2. Endemic Medicine Department; Helwan University; Cairo Egypt

3. National Hepatology & Tropical Medicine Research Institute; Cairo Egypt

4. Tropical Medicine Department; Alexandria University; Alexandria Egypt

5. Tropical Medicine Department; El Azhar University; Cairo Egypt

6. Cairo Fatemic Hospital; Cairo Egypt

7. Pediatric Hepatology; Ain Shams University; Cairo Egypt

8. Internal Medicine Department; Ain Shams University; Cairo Egypt

9. National liver institute; Shebeen El Kom Menoufia Egypt

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13266/fullpdf

Reference24 articles.

1. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies;Estes;Aliment Pharmacol Ther,2015

2. Hepatitis C in the Eastern Mediterranean Region;Esmat;East Mediterr Health J,2013

3. El-Zanaty F Way A Egypt Demographic and Health Survey 2008 Cairo, Egypt Ministry of Health, El-Zanaty and Associates, and Macro International 2009 http://www.measuredhs.com

4. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis;Mokdad;BMC Med,2014

5. Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4;Doss;J Hepatol,2015

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia;Microbial Cell Factories;2024-01-18

2. The ameliorating role of sofosbuvir and daclatasvir on thioacetamide-induced kidney injury in adult albino rats;Anatomy & Cell Biology;2022-12-22

3. Effect of gender difference on psychiatric outcomes for hepatitis C virus patients receiving direct-acting antivirals in Egyptian population: a cohort study;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2022-12-09

4. Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event;Clinics and Research in Hepatology and Gastroenterology;2022-12

5. Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2022-05